Gender difference in the level of high-density lipoprotein cholesterol in elderly Japanese patients with coronary artery disease

Internal Medicine

Volumn 45, Issue 5, 2006, Pages 241-245

  Musha, Haruki ^a   Hayashi, Akio ^a   Kida, Keisuke ^a   Takahashi, Eiji ^a   Suzuki, Kae ^a   Kawasaki, Kensuke ^a   Inoue, Koji ^a   Akashi, Yoshihiro ^a   Tsuchiya, Katsuhiko ^a   Yamauchi, Masahiro ^a   Kunishima, Tomoyuki ^a   Hashimoto, Nobuyuki ^a  

^a ST MARIANNA UNIVERSITY   (Japan)

Author keywords

Coronary artery disease; Elderly Japanese women; Gender difference; High density lipoprotein cholesterol

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTILIPEMIC AGENT; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BEZAFIBRATE; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FENOFIBRATE; FLUINDOSTATIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITRIC ACID DERIVATIVE; PRAVASTATIN; SIMVASTATIN; TICLOPIDINE; TRIACYLGLYCEROL;

AGED; ARTICLE; BLOOD ANALYSIS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; DATA ANALYSIS; DRUG EFFICACY; EXERCISE; FEMALE; HUMAN; HYPERLIPIDEMIA; JAPAN; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; POSTMENOPAUSE; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; AGED, 80 AND OVER; ANTICHOLESTEREMIC AGENTS; CHOLESTEROL, HDL; CORONARY ARTERIOSCLEROSIS; EXERCISE; FEMALE; HUMANS; JAPAN; MALE; POSTMENOPAUSE; RETROSPECTIVE STUDIES; SEX FACTORS; TRIGLYCERIDES;

EID: 33645684763     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.45.1528     Document Type: Article

References (10)

1. Definition and Diagnostic Criteria For Metabolic Syndrome. J Japanese Society of Internal Medicine 94: 794-809, 2005.
2. Alexander CM, Landsman PB, Teutsch SM, Haffher SM. Third National Health and Nutrition Examination Survey (NHANES III) NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants aged 50 years and older. Diabetes 52: 1210-1214, 2003.
3. 2+ precipitation procedure for quantitation of high-density lipoprotein cholesterol. Clin Chem 28: 1379-1388, 1982.
4. Johansson J, Carlson LA, Landow U, Hamsten A. High density lipoproteins and coronary atherosclerosis. A strong inverse relation with the largest particles is confined to normotriglyceridemic patients. Arterioscler Thromb 11: 174-182, 1991.
5. McGovern ME. Taking aim at HDL-C. Raising levels to reduce cardiovascular risk. Postgrad Med 117: 29-30, 33-35, 2005.
6. Okamura T, Hayakawa T, Kadowaki T, et al. The inverse relationship between serum high-density lipoprotein cholesterol level and all-cause mortality in a 9.6-year follow-up study in the Japanese general population. Atherosclerosis 184: 143-150, 2006.
7. Kitamura A, Ito A, Naito Y, et al. High-density lipoprotein cholesterol and premature coronary heart disease in urban Japanese men. Circulation 89: 2533-2539, 1994.
8. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Execusive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285: 2486-2497, 2001.
9. World Health Organization. Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications. Part I: Diagnosis and Classification of Diabetes Mellitus. World Health Organization, Geneva, 1999.
10. Wenger NK, Froelicher ES, Smith LK, et al. Cardiac Rehabilitation. Clinical Practice Guideline No. 17. Rockville, MD: U.S. Department of Health and Human Services. Agency for Health Care Policy and Research and the National Heart, Lung, and Blood Institute. Oct. 1995.